These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 3861482)

  • 21. Auto-antibody to human leukemic cell membrane as detected by immune adherence.
    Yoshida TO; Imai K
    Rev Eur Etud Clin Biol; 1970 Jan; 15(1):61-5. PubMed ID: 5266510
    [No Abstract]   [Full Text] [Related]  

  • 22. Generation of natural killer-like activity in mixed lymphocyte-tumor cell cultures. I. Role of HLA-DR antigens as stimulatory molecules.
    Matera L; Francis MK; Herlyn M; Trucco M; Santoli D
    Nat Immun Cell Growth Regul; 1985; 4(2):90-102. PubMed ID: 3160934
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Search for tumor specific reactivity in human leukemias.
    Nadkarni JS; Nadkarni JJ; Gollerkeri MP
    Indian J Cancer; 1973 Sep; 10(3):338-45. PubMed ID: 4594680
    [No Abstract]   [Full Text] [Related]  

  • 24. [Distribution of the ABO and Rh-D systems in leukemic patients].
    Gurda M; Turowska B
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1970; 94(4):303-8. PubMed ID: 4101120
    [No Abstract]   [Full Text] [Related]  

  • 25. Leukaemia antigens and immunity in man.
    Harris R
    Nature; 1973 Jan; 241(5385):95-100. PubMed ID: 4121144
    [No Abstract]   [Full Text] [Related]  

  • 26. Immunofluorescence studies in human leukemia.
    Bates HA; Bankole RO; Swaim WR
    Blood; 1969 Oct; 34(4):431-40. PubMed ID: 4309683
    [No Abstract]   [Full Text] [Related]  

  • 27. Augmentation of human natural killer cell activity by cyclophosphamide in vitro.
    Sharma B; Vaziri ND
    Cancer Res; 1984 Aug; 44(8):3258-61. PubMed ID: 6589041
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antigens specific for human lymphocytic and myeloid leukemia cells: detection by nonhuman primate antiserums.
    Metzgar RS; Mohanakumar T; Miller DS
    Science; 1972 Dec; 178(4064):986-8. PubMed ID: 4628523
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Solubilization and partial purification of human leukaemic specific antigens.
    Viza D; Davies DA; Harris R
    Nature; 1970 Sep; 227(5264):1249-51. PubMed ID: 4989139
    [No Abstract]   [Full Text] [Related]  

  • 30. The expression of a human B-lymphocyte antigen on cells in different types of leukaemia.
    Turesson I; Berntorp E; Zettervall O
    Acta Med Scand; 1979; 206(1-2):31-6. PubMed ID: 90448
    [No Abstract]   [Full Text] [Related]  

  • 31. HL-A antigens in haematological malignant diseases.
    Jeannet M; Magnin C
    Eur J Clin Invest; 1971 Nov; 2(1):39-42. PubMed ID: 5290218
    [No Abstract]   [Full Text] [Related]  

  • 32. Cytotoxic antibody reactive with cultures of lymphoid cells: occurrence in disease and normal human sera.
    Herberman RB; Nam JM
    J Natl Cancer Inst; 1971 Aug; 47(2):489-94. PubMed ID: 5283788
    [No Abstract]   [Full Text] [Related]  

  • 33. The immunological analysis of soluble human leukemia associated antigens.
    Yong DC; Kwapinski JB
    Can J Microbiol; 1973 Jun; 19(6):741-5. PubMed ID: 4197245
    [No Abstract]   [Full Text] [Related]  

  • 34. [Immunoglobulin levels and complement system activity in leukemia].
    Kiersnowska-Rogowska B; Pietruska Z; Hryszko S; Bielawiec M
    Pol Tyg Lek; 1981 Feb; 36(6):213-6. PubMed ID: 6945567
    [No Abstract]   [Full Text] [Related]  

  • 35. [Distribution of haptoglobin types in leukemic patients].
    Gurda M; Turowska B
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1970; 94(4):309-13. PubMed ID: 4101121
    [No Abstract]   [Full Text] [Related]  

  • 36. [Production of myeloid cell-specific antiserum from HL-60 cell line and its clinical application].
    Nakazawa H; Iga R; Takane K; Mori T; Nakazawa S
    Rinsho Ketsueki; 1983 Jul; 24(7):812-7. PubMed ID: 6195365
    [No Abstract]   [Full Text] [Related]  

  • 37. Leukocyte function in patients with leukemia.
    Rosner F; Valmont I; Kozinn PJ; Caroline L
    Cancer; 1970 Apr; 25(4):835-42. PubMed ID: 5266560
    [No Abstract]   [Full Text] [Related]  

  • 38. Clinical relevance of circulating immune complexes in human leukemia. Association in acute leukemia of the presence of immune complexes with unfavorable prognosis.
    Carpentier NA; Lange GT; Fiere DM; Fournie GJ; Lambert PH; Miescher PA
    J Clin Invest; 1977 Oct; 60(4):874-84. PubMed ID: 268330
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunoglobulins in cases of leukaemias and lymphomas in North India (Chandigarh).
    Datta U; Aikat BK; Sehgal S
    Indian J Med Res; 1971 Dec; 59(12):1950-8. PubMed ID: 5291593
    [No Abstract]   [Full Text] [Related]  

  • 40. Natural killer activity of pediatric patients with acute lymphoblastic leukemia in remission.
    Inada M; Okawa H; Suzuki M; Yata J
    Jpn J Clin Oncol; 1984 Sep; 14(3):335-45. PubMed ID: 6592376
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.